市場調査レポート

商品コード

神経刺激装置の市場規模および予測、世界および地域別シェア、動向、成長機会分析レポート対象範囲：製品別、用途別、エンドユーザー別、地域別

Neurostimulation Devices Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product, Application, End User, and Geography

出版日: 2023年09月28日
発行: The Insight Partners
ページ情報: 英文 172 Pages
納期: 即納可能

価格

PDF (Single User License)

USD 4,450 653,349円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は一度のみ可能です。印刷したもののご利用はPDFのライセンス保持者に限定されます。

PDF (Site License)

USD 6,450 946,989円

レポートPDFを同一事業所（所在地）内のすべての方にご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise License)

USD 8,450 1,240,629円

レポートPDFを企業内すべての方に使用頂けるライセンスです。PDF内のテキスト等のコピーは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=146.82円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

神経刺激装置市場は、2022年の58億200万米ドルから2030年には118億2,500万米ドルに達すると予測されています。同市場は2022年から2030年にかけてCAGR 9.3％で成長すると推定されています。神経疾患の主な発展と脊髄損傷患者の増加が、神経刺激装置市場開拓の主な原動力となっています。しかし、専門家の不足が神経刺激装置市場の成長を妨げています。

非侵襲的治療に対する需要の高まりが、今後の神経刺激装置市場を押し上げる

神経刺激は急速に発展している分野で、神経系に電気的、機械的、磁気的、または熱的な標的刺激を与えて、発火ニューロンや内部ニューロン結合の特性を変化させ、さまざまな神経障害を治療します。非侵襲的神経刺激装置には、電気けいれん療法（ECT）、経皮的電気神経刺激（TENS）、経頭蓋電気刺激（TES）、経頭蓋直流刺激（tDCS）、経頭蓋交流刺激（tACS）、静的磁気刺激、ランダム音刺激、末梢神経刺激、超音波、集束超音波（FUS）（脳神経刺激を含む）などがあります。非侵襲的神経刺激法は精神医学において最も発達しています。

患者や医療提供者は、利便性が高く、痛みがなく、安全で副作用が少ない非侵襲的または低侵襲的な治療法を好むようになっています。さらに、神経疾患でも広く用いられています。非侵襲的治療は、生活の質を改善し、言語、嚥下、認知の問題の影響を軽減することを目的としています。したがって、非侵襲的治療に対する需要の高まりは、今後の神経刺激装置市場の成長を大きく後押しすると思われます。

政府は、脳卒中について人々を教育し、改善された治療法、医療技術、充実した医療保障と医療環境を提供しています。また、同国は非感染性疾患の予防と治療により多くの投資を行っています。さらに、WHOのデータによると、中国の人口の約95%が農村部と都市部で保険に加入しています。これは、政府が低所得者層向けの2つの保険制度、新農村協同医療制度（NRCMS）と都市住民基本医療保険（URBMI）を導入したためです。国民の多くにとって医療費は大きな出費のひとつであるため、この制度が開始されました。中国政府によるこれらの取り組みは、国民が健康増進のために手術を受けることを奨励するものです。神経刺激装置市場は、日本や中国などの医療機器産業の市場開拓の高まりによっても成長が見込まれています。さらに、神経学における革新的な技術動向や、人工知能（AI）や機械学習（ML）の急速な導入は、この地域の市場を牽引するいくつかの要因です。

さらに、同国における神経刺激装置市場の成長は、脳卒中の有病率の上昇と発症率の増加に起因しています。脳神経外科手術には高度な機器と高度な資格を持つ医療専門家が必要です。ドイツには高度な資格を持つ神経外科医がおり、彼らは最新のプロトコールと手術手順に従っています。同国の神経センターには、国際的な品質基準を満たす最新の診断機器と低侵襲手術機器があります。

キングス・カレッジ・ロンドンが欧州脳卒中連合（Stroke Alliance for Europe）のために実施した報告書「Burden of Stroke in Europe」に掲載されたデータによると、ドイツでは年間約88,922件の脳卒中が発生しており、これは人口10万人当たり51.7件の脳卒中です。ドイツにおける脳卒中の有病率は526,774人で、これは人口10万人あたり338.5人です。ドイツでは脳卒中による死亡率も高く、i.年間75,861人が脳卒中で死亡しています。欧州における脳卒中の負担」報告書によると、2035年までに脳卒中患者は30％増加し、脳卒中の有病率は2035年末までに19％に増加すると予想されています。2022年12月、ドイツでは約40万人が脳卒中に罹患しており、人口動態の高齢化によりその数は増加しています。若年層を含め、神経変性疾患を患う人が増えており、ドイツでは200万人以上が認知症やパーキンソン病を患っています。ドイツアルツハイマー病患者協会によると、2020年にはアルツハイマー病が原因で9450人が死亡し、最多を記録します。アルツハイマーの診断による入院と死亡の増加は、ドイツの高齢化に大きく依存しています。ドイツでは、65歳以上の人口が33％増加し、2020年には1,830万人に達します。

このように、脳卒中の発生率が著しく増加し、高齢化人口が増加しているため、神経障害の症例が増加しており、ドイツにおける神経刺激装置市場の成長を牽引しています。さらに、政府の支援策や神経学の研究も市場の成長を後押ししています。したがって、上記の要因が2022～2030年の神経刺激装置市場の成長に寄与すると考えられます。

神経刺激装置市場は、製品、用途、エンドユーザー、地域によって区分されます。製品別では、脊髄刺激装置、脳深部刺激装置、仙骨神経刺激装置、迷走神経刺激装置、その他に区分されます。脊髄刺激装置セグメントは2022年に大きな市場シェアを占め、2022～2030年にはより高いCAGRを記録すると予測されています。神経刺激装置市場は、用途別に疼痛管理、てんかん、尿失禁・便失禁、パーキンソン病、その他に区分されます。疼痛管理分野は2022年に大きな市場シェアを占め、2022～2030年に高いCAGRを記録すると予測されています。神経刺激装置市場は、エンドユーザー別に病院、専門クリニック、その他に二分されます。病院セグメントは2022年に市場の最大シェアを占め、専門クリニックセグメントは2022～2030年に市場で最も高いCAGRを記録すると予測されています。専門クリニックは、高水準の臨床結果を保証する卓越したセンターです。これらのセンターは神経疾患の診断、治療、管理に特化しており、高度な訓練を受けた医師、救急隊員、専門スキルを持つ看護職員を雇用しています。ハイエンドの機器を使用し、事前に定義されたプロトコルを遵守するだけでなく、より良いサービスの質は、他の施設よりも患者に付加価値を与えます。こうしたクリニックはサービスを合理化し、利便性の高いケアを提供します。

さらに、専門クリニックでは、リラックスできる落ち着いた環境の中で、医学的に推奨され、管理された治療が受けられます。このようなクリニックでは、いくつかの診断手順を提供するほか、パーキンソン病やアルツハイマー病、振戦などを患う患者の日常的なケア方法に関する教育も行っています。このような患者は、病気の重症度を評価するために、隙間のある薬を服用して運動症状の検査を受けるかもしれないです。費用対効果や待ち時間の短縮といった要因が、このセグメントの成長を後押ししています。

これらの疾患の世界の有病率の上昇により、これらの疾患の診断と治療のために専門クリニックを訪れる患者が増加しており、より良い治療と専門的なサービスを提供する専門クリニックの数が世界レベルで増加しています。さらに、市場の成長は、世界中で専門クリニックの普及率が高まっていることに起因しています。例えば、2022年7月、オハイオ州立大学ウェクスナー・メディカル・センターの神経学チームは、新しい専門クリニックであるパーキンソン病集学的クリニックを開設しました。このクリニックは、パーキンソン病患者が異なる場所で複数の予約を取ることなく、必要な治療をすべて受けられる「ワンストップショップ」として機能します。このクリニックでは、患者は、セラピスト、神経心理学者、サブスペシャリティ訓練を受けた運動神経科医、高度実践医療従事者を含むチームとともに、こわばり、記憶障害、ふらつき/協調性低下、震え、疲労などの症状に対処することができます。

食品医薬品局（FDA）、国立がん研究所（NCI）、保健予防省（MoHAP）、国家変革プログラム（NTP）などは、神経刺激装置市場に関する報告書を作成する際に参照した一次情報および二次情報の一部です。

List Of Tables

Table 1. Neurostimulation Devices Market Segmentation
Table 2. North America Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 3. North America Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 4. North America Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 5. US Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 6. US Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 7. US Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 8. Canada Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 9. Canada Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 10. Canada Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 11. Mexico Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 12. Mexico Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 13. Mexico Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 14. Europe Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 15. Europe Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 16. Europe Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 17. Germany Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 18. Germany Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 19. Germany Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 20. UK Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 21. UK Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 22. UK Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 23. France Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 24. France Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 25. France Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 26. Italy Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 27. Italy Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 28. Italy Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 29. Spain Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 30. Spain Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 31. Spain Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 32. Rest of Europe Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 33. Rest of Europe Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 34. Rest of Europe Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 35. Asia Pacific Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 36. Asia Pacific Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 37. Asia Pacific Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 38. China Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 39. China Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 40. China Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 41. Japan Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 42. Japan Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 43. Japan Neurostimulation Devices Market, by End User- Revenue and Forecast to 2030 (US$ Million)
Table 44. India Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 45. India Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 46. India Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 47. Australia Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 48. Australia Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 49. Australia Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 50. South Korea Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 51. South Korea Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 52. South Korea Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 53. Rest of Asia Pacific Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 54. Rest of Asia Pacific Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 55. Rest of Asia Pacific Neurostimulation Devices Market, by End User- Revenue and Forecast to 2030 (US$ Million)
Table 56. Middle East & Africa Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 57. Middle East & Africa Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 58. Middle East & Africa Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 59. Saudi Arabia Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 60. Saudi Arabia Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 61. Saudi Arabia Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 62. South Africa Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 63. South Africa Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 64. South Africa Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 65. UAE Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 66. UAE Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 67. UAE Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 68. Rest of Middle East & Africa Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 69. Rest of Middle East & Africa Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 70. Rest of Middle East & Africa Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 71. South & Central America Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 72. South & Central America: Neurostimulation Devices Market, By Application - Revenue and Forecast to 2030 (US$ Million)
Table 73. South & Central America: Neurostimulation Devices Market, By End User - Revenue and Forecast to 2030 (US$ Million)
Table 74. Brazil Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 75. Brazil: Neurostimulation Devices Market, By Application - Revenue and Forecast to 2030 (US$ Million)
Table 76. Brazil: Neurostimulation Devices Market, By End User - Revenue and Forecast to 2030 (US$ Million)
Table 77. Argentina Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 78. Argentina: Neurostimulation Devices Market, By Application - Revenue and Forecast to 2030 (US$ Million)
Table 79. Argentina: Neurostimulation Devices Market, By End User - Revenue and Forecast to 2030 (US$ Million)
Table 80. Rest of South & Central Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 81. Rest of South & Central America: Neurostimulation Devices Market, By Application - Revenue and Forecast to 2030 (US$ Million)
Table 82. Rest of South & Central America: Neurostimulation Devices Market, By End User - Revenue and Forecast to 2030 (US$ Million)
Table 83. Organic Developments Done by Companies
Table 84. Inorganic Developments Done by Companies
Table 85. Glossary of Terms, Neurostimulation Devices Market

List Of Figures

Figure 1. Neurostimulation Devices Market Segmentation, By Geography
Figure 2. Global - PEST Analysis
Figure 3. Neurostimulation Devices Market: Key Industry Dynamics
Figure 4. Neurostimulation Devices Market: Impact Analysis of Drivers and Restraints
Figure 5. Neurostimulation Devices Market Revenue (US$ Mn), 2020 - 2030
Figure 6. Global Neurostimulation Devices Market, By Geography Forecast Analysis, 2022 & 2030
Figure 7. Neurostimulation Devices Market Revenue Share, by Product 2022 & 2030 (%)
Figure 8. Spinal Cord Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Deep Brain Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Sacral Nerve Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Vagus Nerve Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Neurostimulation Devices Market Revenue Share, by Application 2022 & 2030 (%)
Figure 14. Pain Management: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Epilepsy: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Urinary and Fecal Incontinence: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Parkinson's Disease: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Neurostimulation Devices Market Revenue Share, by End User 2022 & 2030 (%)
Figure 20. Hospitals & Clinics: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Specialty Clinics: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. North America: Neurostimulation Devices Market, by Key Country - Revenue (2022) (US$ Million)
Figure 24. North America Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. North America: Neurostimulation Devices Market, by Country, 2022 & 2030 (%)
Figure 26. US: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. Canada: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 28. Mexico: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 29. Europe: Neurostimulation Devices Market, by Key Country - Revenue (2022) (US$ Million)
Figure 30. Europe Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 31. Europe: Neurostimulation Devices Market, by Country, 2022 & 2030 (%)
Figure 32. Germany: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 33. UK: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 34. France: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 35. Italy: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 36. Spain: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 37. Rest of Europe: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 38. Asia Pacific: Neurostimulation Devices Market, by Key Country - Revenue (2022) (US$ Million)
Figure 39. Asia Pacific Neurostimulation Devices Market Revenue and Forecast to 2030 (US$ Million)
Figure 40. Asia Pacific: Neurostimulation Devices Market, by Country, 2022 & 2030 (%)
Figure 41. China: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 42. Japan: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 43. India: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 44. Australia: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 45. South Korea: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 46. Rest of Asia Pacific: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 47. Middle East & Africa: Neurostimulation Devices Market, by Key Country - Revenue (2022) (US$ Million)
Figure 48. Middle East & Africa Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 49. Middle East & Africa: Neurostimulation Devices Market, by Country, 2022 & 2030 (%)
Figure 50. Saudi Arabia: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 51. South Africa: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 52. UAE: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 53. Rest of Middle East & Africa: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 54. South & Central America: Neurostimulation Devices Market, By Key Country - Revenue (2022) (US$ Million)
Figure 55. South & Central America: Neurostimulation Devices Market- Revenue and Forecasts to 2030 (US$ Million)
Figure 56. South & Central America: Neurostimulation Devices Market Share by Country - 2022 & 2030, (%)
Figure 57. Brazil: Neurostimulation Devices Market- Revenue and Forecasts to 2030 (US$ Million)
Figure 58. Argentina: Neurostimulation Devices Market- Revenue and Forecasts to 2030 (US$ Million)
Figure 59. Rest of South & Central America: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Product Code: TIPRE00002778

The neurostimulation devices market is projected to reach US$ 11.825 billion in 2030 from US$ 5.802 billion in 2022. The market is estimated to grow with a CAGR of 9.3% from 2022 to 2030. The growing prevalence of neurological diseases and increasing cases of spinal cord injury are the key driving factors behind the neurostimulation devices market development. However, lack of expert professionals is hampering the neurostimulation devices market growth.

Rising Demand for Noninvasive Treatment to Boost the Neurostimulation Devices Market in Future

Neurostimulation is a rapidly evolving field that uses targeted electrical, mechanical, magnetic, or thermal stimulation of the nervous system to alter the properties of firing neuronal and internal neuronal connectivity to treat various neurological disorders. Noninvasive neurostimulation devices include electroconvulsive therapy (ECT), transcutaneous electrical nerve stimulation (TENS), transcranial electrical stimulation (TES), transcranial direct current stimulation (tDCS), transcranial alternating current stimulation (tACS), static magnetic stimulation, random sound stimulation, peripheral nerve stimulation, ultrasound, and focused ultrasound (FUS), including cranial nerve stimulation. Noninvasive neurostimulation techniques are the most developed in psychiatry.

Patients and healthcare providers increasingly prefer noninvasive or minimally invasive treatment options as they are convenient, painless, safe, and have minimal side effects. In addition, it is widely used in neurological diseases. Noninvasive treatments aim to improve the quality of life and reduce the impact of speech, swallowing, and cognitive problems. Therefore, growing demand for noninvasive treatments would significantly fuel the neurostimulation devices market growth in the future.

The government is educating people about stroke and offering improved treatment, medical technology, and enhanced healthcare coverage and healthcare environment. Also, the country has invested more in preventing and treating noncommunicable diseases. Additionally, as per the data of WHO, ~95% of the population of China is insured in rural and urban areas, as the government introduced two insurance programs for low-income groups: the New Rural Cooperative Medical System (NRCMS) and Urban Resident Basic Medical Insurance (URBMI). The programs were launched as the cost of health is one of the significant expenses for most of the population. These initiatives by the Chinese government would encourage the population to undergo surgeries to improve health. The neurostimulation devices market is also expected to grow due to the rising development of the medical device industry in countries such as Japan and China. In addition, innovative technology trends in neurology and the rapid adoption of artificial intelligence (AI) and machine learning (ML) are a few factors that drive the market in the region.

Furthermore, the neurostimulation devices market growth in the country is attributed to the rising prevalence of stroke and increasing incidence. Neurosurgery requires advanced equipment and highly qualified medical professionals. Germany has highly qualified neurosurgeons; they follow the latest protocols and surgical procedures. Neurology centers in the country have the most modern diagnostic and minimally invasive surgical devices that meet international quality standards.

According to the data published in the Burden of Stroke in Europe report conducted by King's College London for the Stroke Alliance for Europe, Germany records around 88,922 stroke cases annually, which is 51.7 strokes per 100,000 inhabitants. The prevalence of stroke in Germany was ~ 526,774 that accounts for 338.5 strokes per 100,000 residents. Germany also has a significant mortality rate of stroke, i.e., 75,861 deaths due to stroke per year. According to the Burden of Stroke in Europe report, it is expected that stroke cases will increase by 30% by 2035, and the prevalence of stroke will grow to 19% by the end of 2035.approximately 400,000 people were affected with the disease in Germany in December 2022, and the numbers are increasing due to demographic aging. More and more people, including younger people, suffer from neurodegenerative diseases; in Germany, more than 2 million people have dementia or Parkinson's. According to the German Association for Alzheimer's Patients, in 2020, 9,450 deaths were caused due to Alzheimer's, recording the highest figure. The increase in hospitalizations and deaths with Alzheimer's diagnosis is highly dependent on the aging population in Germany. In Germany, people aged 65 and above had increased by ~33% and reached 18.3 million in 2020.

Thus, significantly growing incidence of stroke and rising aging population resulting in growing cases of neurological disorders drive the neurostimulation devices market growth in Germany. Furthermore, supportive government initiatives and research in neurology also boost market growth. Therefore, the factors mentioned above are likely to contribute to the neurostimulation devices market growth during 2022-2030.

The neurostimulation devices market is segmented on the basis of product, application, end user, and geography. Based on product, the market is segmented into spinal cord stimulator, deep brain stimulator, sacral nerve stimulator, vagus nerve stimulator, and others. The spinal cord stimulator segment held a larger market share in 2022 and the same is anticipated to register a higher CAGR during 2022-2030. The neurostimulation devices market, by application, is segmented into pain management, epilepsy, urinary and fecal incontinence, Parkinson's disease, and others. The pain management segment held a larger market share in 2022 and the same is anticipated to register a higher CAGR during 2022-2030. The neurostimulation devices market, by end user, is bifurcated into hospitals, specialty clinics, and others. The hospitals segment held the largest share of the market in 2022 and specialty clinics segment is anticipated to register the highest CAGR in the market during 2022-2030. Specialty clinics are centers of excellence assured to deliver high standards of clinical outcomes. These centers are dedicated to diagnosing, treating, and managing neurological disorders and employ highly trained doctors, paramedics, and nursing personnel with specialized skills. Besides adhering to predefined protocols using high-end equipment, better service quality adds value to patients more than other facilities. These clinics streamline services and enhance convenient care.

In addition, specialty clinics provide medically recommended and supervised treatments in a relaxing and calming environment. These clinics also help to educate people regarding daily care routines for patients who have Parkinson's disease and Alzheimer's disease, tremors, and other such conditions, apart from providing several diagnostic procedures. These patients might undergo testing of motor symptoms by taking medications with gaps to assess the disease severity. Factors such as cost-effectiveness and shorter waiting times fuel the segment growth.

A global rise in the prevalence of these conditions has led to a growing number of patients visiting specialty clinics to diagnose and treat these conditions, with an increasing number of specialty clinics on the global level that offer better treatment and specialized services. In addition, the market growth is attributable to the growing penetration rate of specialty clinics across the globe. For instance, in July 2022, the neurology teams of Ohio State University Wexner Medical Center opened a new specialty clinic, the Parkinson's Disease Multidisciplinary Clinic. The clinic acts as a "one-stop shop" for Parkinson's disease patients to receive all the care they need without taking multiple appointments in different locations. At the clinic, patients can address symptoms such as stiffness, memory difficulties, unsteadiness/poor coordination, tremors, and fatigue with a team that includes therapists, neuropsychologists, subspecialty-trained movement neurologists, and advanced practice providers.

The Food and Drug Administration (FDA), National Cancer Institute (NCI), Ministry of Health and Prevention (MoHAP), and National Transformation Program (NTP) are among some of the primary and secondary sources referred to while preparing the report on the neurostimulation devices market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the neurostimulation devices market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the neurostimulation devices market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth global market trends and outlook coupled with the factors driving the neurostimulation devices market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights
2.2 Neurostimulation Devices Market, by Geography (US$ Million)

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Neurostimulation Devices Market Landscape

4.1 Overview
4.2 PEST Analysis
- 4.2.1 Global PEST Analysis

5. Neurostimulation Devices Market - Key Industry Dynamics

5.1 Market Drivers
- 5.1.1 Increasing Prevalence of Neurological Disorders
- 5.1.2 Rising Cases of Spinal Cord Injury
5.2 Market Restraints
- 5.2.1 Lack of Expert Professionals
5.3 Market Opportunities
- 5.3.1 Growing Advances and Approvals for Neurostimulation Devices
5.4 Future Trends
- 5.4.1 Rising Demand for Noninvasive Treatment
5.5 Impact Analysis

6. Neurostimulation Devices Market - Global Market Analysis

6.1 Neurostimulation Devices Market Revenue (US$ Mn), 2022 - 2030

7. Global Neurostimulation Devices Market - Revenue and Forecast to 2030 - by Product

7.1 Overview
7.2 Neurostimulation Devices Market Revenue Share, by Product 2022 & 2030 (%)
7.3 Spinal Cord Stimulator
- 7.3.1 Overview
- 7.3.2 Spinal Cord Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Deep Brain Stimulator
- 7.4.1 Overview
- 7.4.2 Deep Brain Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Sacral Nerve Stimulator
- 7.5.1 Overview
- 7.5.2 Sacral Nerve Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Vagus Nerve Stimulator
- 7.6.1 Overview
- 7.6.2 Vagus Nerve Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
7.7 Others
- 7.7.1 Overview
- 7.7.2 Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

8. Global Neurostimulation Devices Market - Revenue and Forecast to 2030 - by Application

8.1 Overview
8.2 Neurostimulation Devices Market Revenue Share, by Application 2022 & 2030 (%)
8.3 Pain Management
- 8.3.1 Overview
- 8.3.2 Pain Management: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Epilepsy
- 8.4.1 Overview
- 8.4.2 Epilepsy: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Urinary and Fecal Incontinence
- 8.5.1 Overview
- 8.5.2 Urinary and Fecal Incontinence: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Parkinson's Disease
- 8.6.1 Overview
- 8.6.2 Parkinson's Disease: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
8.7 Others
- 8.7.1 Overview
- 8.7.2 Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

9. Global Neurostimulation Devices Market - Revenue and Forecast to 2030 - by End User

9.1 Overview
9.2 Neurostimulation Devices Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Hospitals
- 9.3.1 Overview
- 9.3.2 Hospitals: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Specialty Clinics
- 9.4.1 Overview
- 9.4.2 Specialty Clinics: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Others
- 9.5.1 Overview
- 9.5.2 Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

10. Neurostimulation Devices Market - Revenue and Forecast to 2030 - Geographic Analysis

10.1 North America: Neurostimulation Devices Market
- 10.1.1 Overview
- 10.1.2 North America: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  - 10.1.2.1 North America: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
  - 10.1.2.2 North America: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
  - 10.1.2.3 North America: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
- 10.1.3 North America: Neurostimulation Devices Market, by Country, 2022 & 2030 (%)
  - 10.1.3.1 US: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
  - 10.1.3.2 US: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.3.2.1 US: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
    - 10.1.3.2.2 US: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
    - 10.1.3.2.3 US: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
  - 10.1.3.3 Canada: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
  - 10.1.3.4 Canada: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.3.4.1 Canada: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
    - 10.1.3.4.2 Canada: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
    - 10.1.3.4.3 Canada: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
  - 10.1.3.5 Mexico: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
  - 10.1.3.6 Mexico: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.3.6.1 Mexico: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
    - 10.1.3.6.2 Mexico: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
    - 10.1.3.6.3 Mexico: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
10.2 Europe: Neurostimulation Devices Market
- 10.2.1 Overview
- 10.2.2 Europe: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  - 10.2.2.1 Europe: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
  - 10.2.2.2 Europe: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
  - 10.2.2.3 Europe: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
- 10.2.3 Europe: Neurostimulation Devices Market, by Country, 2022 & 2030 (%)
  - 10.2.3.1 Germany: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
  - 10.2.3.2 Germany: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.2.3.2.1 Germany: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
    - 10.2.3.2.2 Germany: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
    - 10.2.3.2.3 Germany: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
  - 10.2.3.3 UK: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
  - 10.2.3.4 UK: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.2.3.4.1 UK: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
    - 10.2.3.4.2 UK: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
    - 10.2.3.4.3 UK: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
  - 10.2.3.5 France: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
  - 10.2.3.6 France: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.2.3.6.1 France: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
    - 10.2.3.6.2 France: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
    - 10.2.3.6.3 France: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
  - 10.2.3.7 Italy: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
  - 10.2.3.8 Italy: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.2.3.8.1 Italy: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
    - 10.2.3.8.2 Italy: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
    - 10.2.3.8.3 Italy: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
  - 10.2.3.9 Spain: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
  - 10.2.3.10 Spain: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.2.3.10.1 Spain: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
    - 10.2.3.10.2 Spain: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
    - 10.2.3.10.3 Spain: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
  - 10.2.3.11 Rest of Europe: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
  - 10.2.3.12 Rest of Europe: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.2.3.12.1 Rest of Europe: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
    - 10.2.3.12.2 Rest of Europe: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
    - 10.2.3.12.3 Rest of Europe: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
10.3 Asia Pacific: Neurostimulation Devices Market
- 10.3.1 Overview
- 10.3.2 Asia Pacific: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  - 10.3.2.1 Asia Pacific: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
  - 10.3.2.2 Asia Pacific: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
  - 10.3.2.3 Asia Pacific: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
- 10.3.3 Asia Pacific: Neurostimulation Devices Market, by Country, 2022 & 2030 (%)
  - 10.3.3.1 China: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
  - 10.3.3.2 China: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.3.3.2.1 China: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
    - 10.3.3.2.2 China: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
    - 10.3.3.2.3 China: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
  - 10.3.3.3 Japan: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
  - 10.3.3.4 Japan: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.3.3.4.1 Japan: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
    - 10.3.3.4.2 Japan: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
    - 10.3.3.4.3 Japan: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
  - 10.3.3.5 India: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
  - 10.3.3.6 India: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.3.3.6.1 India: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
    - 10.3.3.6.2 India: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
    - 10.3.3.6.3 India: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
  - 10.3.3.7 Australia: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
  - 10.3.3.8 Australia: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.3.3.8.1 Australia: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
    - 10.3.3.8.2 Australia: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
    - 10.3.3.8.3 Australia: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
  - 10.3.3.9 South Korea: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
  - 10.3.3.10 South Korea: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.3.3.10.1 South Korea: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
    - 10.3.3.10.2 South Korea: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
    - 10.3.3.10.3 South Korea: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
  - 10.3.3.11 Rest of Asia Pacific: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
  - 10.3.3.12 Rest of Asia Pacific: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.3.3.12.1 Rest of Asia Pacific: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
    - 10.3.3.12.2 Rest of Asia Pacific: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
    - 10.3.3.12.3 Rest of Asia Pacific: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
10.4 Middle East & Africa Neurostimulation Devices Market
- 10.4.1 Overview
- 10.4.2 Middle East & Africa: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  - 10.4.2.1 Middle East & Africa: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
  - 10.4.2.2 Middle East & Africa: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
  - 10.4.2.3 Middle East & Africa: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
- 10.4.3 Middle East & Africa: Neurostimulation Devices Market, by Country, 2022 & 2030 (%)
  - 10.4.3.1 Saudi Arabia: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
  - 10.4.3.2 Saudi Arabia: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.4.3.2.1 Saudi Arabia: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
    - 10.4.3.2.2 Saudi Arabia: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
    - 10.4.3.2.3 Saudi Arabia: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
  - 10.4.3.3 South Africa: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
  - 10.4.3.4 South Africa: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.4.3.4.1 South Africa: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
    - 10.4.3.4.2 South Africa: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
    - 10.4.3.4.3 South Africa: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
  - 10.4.3.5 UAE: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
  - 10.4.3.6 UAE: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.4.3.6.1 UAE: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
    - 10.4.3.6.2 UAE: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
    - 10.4.3.6.3 UAE: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
  - 10.4.3.7 Rest of Middle East & Africa: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
  - 10.4.3.8 Rest of Middle East & Africa: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.4.3.8.1 Rest of Middle East & Africa: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
    - 10.4.3.8.2 Rest of Middle East & Africa: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
    - 10.4.3.8.3 Rest of Middle East & Africa: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
10.5 South & Central America: Neurostimulation Devices Market
- 10.5.1 Overview
- 10.5.2 South & Central America: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  - 10.5.2.1 South & Central America: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
  - 10.5.2.2 South & Central America: Neurostimulation Devices Market, By Application, 2020-2030 (US$ Million)
  - 10.5.2.3 South & Central America: Neurostimulation Devices Market, By End User, 2020-2030 (US$ Million)
- 10.5.3 South & Central America: Neurostimulation Devices Market Share by Country - 2022 & 2030, (%)
  - 10.5.3.1 Brazil: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
  - 10.5.3.2 Brazil: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.5.3.2.1 Brazil: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
    - 10.5.3.2.2 Brazil: Neurostimulation Devices Market, By Application, 2020-2030 (US$ Million)
    - 10.5.3.2.3 Brazil: Neurostimulation Devices Market, By End User, 2020-2030 (US$ Million)
  - 10.5.3.3 Argentina: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
  - 10.5.3.4 Argentina: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.5.3.4.1 Argentina: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
    - 10.5.3.4.2 Argentina: Neurostimulation Devices Market, By Application, 2020-2030 (US$ Million)
    - 10.5.3.4.3 Argentina: Neurostimulation Devices Market, By End User, 2020-2030 (US$ Million)
  - 10.5.3.5 Rest of South & Central America: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
  - 10.5.3.6 Rest of South & Central America: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.5.3.6.1 Rest of South & Central America: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
    - 10.5.3.6.2 Rest of South & Central America: Neurostimulation Devices Market, By Application, 2020-2030 (US$ Million)
    - 10.5.3.6.3 Rest of South & Central America: Neurostimulation Devices Market, By End User, 2020-2030 (US$ Million)

11. Neurostimulation Devices Market-Industry Landscape

11.1 Overview
11.2 Organic Developments
- 11.2.1 Overview
11.3 Inorganic Developments
- 11.3.1 Overview

12. Company Profiles

12.1 Medtronic Plc
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Boston Scientific Corp
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Abbott Laboratories
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Nevro Corp
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 LivaNova Plc
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Synapse Biomedical Inc.
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Nalu Medical, Inc
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 ElectroCore Inc
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 MicroTransponder Inc.
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 Mainstay Medical
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments

13. Appendix

13.1 About Us
13.2 Glossary of Terms

神経刺激装置の市場規模および予測、世界および地域別シェア、動向、成長機会分析レポート対象範囲：製品別、用途別、エンドユーザー別、地域別

Neurostimulation Devices Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product, Application, End User, and Geography

目次

第1章イントロダクション

第2章エグゼクティブサマリー

第3章調査手法

第4章神経刺激装置市場情勢

第5章神経刺激装置市場-主要産業力学

第6章神経刺激装置市場：世界市場分析

第7章神経刺激装置の世界市場：2030年までの収益と予測：製品別分析

第8章神経刺激装置の世界市場：2030年までの収益と予測：用途別分析

第9章神経刺激装置の世界市場：2030年までの収益と予測：エンドユーザー別分析

第10章神経刺激装置の世界市場：2030年までの収益と予測：地域別分析

第11章神経刺激装置市場-業界情勢

第12章企業プロファイル

第13章付録

List Of Tables

List Of Figures

Reasons to Buy:

Table Of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Neurostimulation Devices Market Landscape

5. Neurostimulation Devices Market - Key Industry Dynamics

6. Neurostimulation Devices Market - Global Market Analysis

7. Global Neurostimulation Devices Market - Revenue and Forecast to 2030 - by Product

8. Global Neurostimulation Devices Market - Revenue and Forecast to 2030 - by Application

9. Global Neurostimulation Devices Market - Revenue and Forecast to 2030 - by End User

10. Neurostimulation Devices Market - Revenue and Forecast to 2030 - Geographic Analysis

11. Neurostimulation Devices Market-Industry Landscape

12. Company Profiles

13. Appendix

神経刺激装置の市場規模および予測、世界および地域別シェア、動向、成長機会分析レポート対象範囲：製品別、用途別、エンドユーザー別、地域別

Neurostimulation Devices Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product, Application, End User, and Geography

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 神経刺激装置市場情勢

第5章 神経刺激装置市場-主要産業力学

第6章 神経刺激装置市場：世界市場分析

第7章 神経刺激装置の世界市場：2030年までの収益と予測：製品別分析

第8章 神経刺激装置の世界市場：2030年までの収益と予測：用途別分析

第9章 神経刺激装置の世界市場：2030年までの収益と予測：エンドユーザー別分析

第10章 神経刺激装置の世界市場：2030年までの収益と予測：地域別分析

第11章 神経刺激装置市場-業界情勢

第12章 企業プロファイル

第13章 付録

List Of Tables

List Of Figures

Reasons to Buy:

Table Of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Neurostimulation Devices Market Landscape

5. Neurostimulation Devices Market - Key Industry Dynamics

6. Neurostimulation Devices Market - Global Market Analysis

7. Global Neurostimulation Devices Market - Revenue and Forecast to 2030 - by Product

8. Global Neurostimulation Devices Market - Revenue and Forecast to 2030 - by Application

9. Global Neurostimulation Devices Market - Revenue and Forecast to 2030 - by End User

10. Neurostimulation Devices Market - Revenue and Forecast to 2030 - Geographic Analysis

11. Neurostimulation Devices Market-Industry Landscape

12. Company Profiles

13. Appendix

第1章イントロダクション

第2章エグゼクティブサマリー

第3章調査手法

第4章神経刺激装置市場情勢

第5章神経刺激装置市場-主要産業力学

第6章神経刺激装置市場：世界市場分析

第7章神経刺激装置の世界市場：2030年までの収益と予測：製品別分析

第8章神経刺激装置の世界市場：2030年までの収益と予測：用途別分析

第9章神経刺激装置の世界市場：2030年までの収益と予測：エンドユーザー別分析

第10章神経刺激装置の世界市場：2030年までの収益と予測：地域別分析

第11章神経刺激装置市場-業界情勢

第12章企業プロファイル

第13章付録